Preeclampsia: Multiple approaches for a multifactorial disease

DMM Disease Models and Mechanisms

Volumn 5, Issue 1, 2012, Pages 9-18

  Pennington, Kathleen A ^a   Schlitt, Jessica M ^a   Jackson, Daniel L ^a   Schulz, Laura C ^a   Schust, Danny J ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FMS LIKE TYROSINE KINASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL INJURY; CLINICAL RESEARCH; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; HYPERTENSION; HYPOXEMIA; MATERNAL UTERINE VASCULAR REMODELING; MOTHER FETUS RELATIONSHIP; NONHUMAN; OXYGENATION; PATHOPHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; TROPHOBLAST; UTERINE BLOOD VESSEL;

ANIMALS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; TRANSLATIONAL MEDICAL RESEARCH;

ANIMALIA;

EID: 84855881398     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.008516     Document Type: Article

References (93)

1. Abitbol. M. M. (1982). Simplified technique to produce toxemia in the rat: considerations on cause of toxemia. Clin. Exp. Hypertens. B 1, 93-103. (Pubitemid 12066049)
2. Abou-Nassar, K., Carrier, M., Ramsay, T. and Rodger, M. A. (2011). The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis. Thromb. Res. 128, 77-85.
3. ACOG (2002). American College of Obstetricians and Gynecologists practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int. J. Gynaecol. Obstet. 77, 67-75.
4. Aquilina, J. and Harrington, K. (1996). Pregnancy hypertension and uterine artery Doppler ultrasound. Curr. Opin. Obstet. Gynecol. 8, 435-440. (Pubitemid 26424340)
5. Askie, L. M., Duley, L., Henderson-Smart, D. J. and Stewart, L. A. (2007). Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369, 1791-1798. (Pubitemid 46782996)
6. Balta, O., Boztosun, A., Deveci, K., Gulturk, S., Ekici, F., Kaya, A., Cetin, A. and Cetin, M. (2011). Reduced uterine perfusion pressure model is not successful to mimic severe preeclampsia. Placenta 32, 675-680.
7. Basso, O., Christensen, K. and Olsen, J. (2001). Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals? Epidemiology 12, 624-629. (Pubitemid 33134522)
8. Benyo, D. F., Smarason, A., Redman, C. W., Sims, C. and Conrad, K. P. (2001). Expression of inflammatory cytokines in placentas from women with preeclampsia. J. Clin. Endocrinol. Metab. 86, 2505-2512. (Pubitemid 32545699)
9. Berg, C. J., Mackay, A. P., Qin, C. and Callaghan, W. M. (2009). Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. Obstet. Gynecol. 113, 1075-1081.
10. Brosnihan, K. B., Hering, L., Dechend, R., Chappell, M. C. and Herse, F. (2010). Increased angiotensin II in the mesometrial triangle of a transgenic rat model of preeclampsia. Hypertension 55, 562-566.
11. Brozos, C., Mavrogianni, V. S., Fthenakis, G. C. (2011). Treatment and control of peri-parturient metabolic diseases: pregnancy toxemia, hypocalcemia, hypomagnesemia. Vet. Clin. North Am. Food. Anim. Pract. 27, 105-113.
12. Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J. C. and Giguere, Y. (2010). Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet. Gynecol. 116, 402-414.
13. Burton, G. J. and Jauniaux, E. (2011). Oxidative stress. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 287-299.
14. Burton, G. J., Charnock-Jones, D. S. and Jauniaux, E. (2009). Regulation of vascular growth and function in the human placenta. Reproduction 138, 895-902.
15. Caniggia, I. and Winter, J. L. (2002). Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies - a review. Placenta 23 Suppl. A, S47-S57.
16. Caniggia, I., Winter, J., Lye, S. J. and Post, M. (2000). Oxygen and placental development during the first trimester: implications for the pathophysiology of preeclampsia. Placenta 21 Suppl. A, S25-S30.
17. Carty, D. M., Siwy, J., Brennand, J. E., Zurbig, P., Mullen, W., Franke, J., McCulloch, J. W., Roberts, C. T., North, R. A., Chappell, L. C. et al. (2011). Urinary proteomics for prediction of preeclampsia. Hypertension 57, 561-569.
18. Cnossen, J. S., Vollebregt, K. C., de Vrieze, N., ter Riet, G., Mol, B. W., Franx, A., Khan, K. S. and van der Post, J. A. (2008). Accuracy of mean arterial pressure and blood pressure measurements in predicting preeclampsia: systematic review and meta-analysis. BMJ 336, 1117-1120. (Pubitemid 351731742)
19. Craven, C. M., Morgan, T. and Ward, K. (1998). Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta 19, 241-252. (Pubitemid 28224792)
20. Davisson, R. L., Hoffmann, D. S., Butz, G. M., Aldape, G., Schlager, G., Merrill, D. C., Sethi, S., Weiss, R. M. and Bates, J. N. (2002). Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 39, 337-342. (Pubitemid 34165145)
21. Dechend, R., Gratze, P., Wallukat, G., Shagdarsuren, E., Plehm, R., Brasen, J. H., Fiebeler, A., Schneider, W., Caluwaerts, S., Vercruysse, L. et al. (2005). Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension 45, 742-746. (Pubitemid 40418375)
22. Dokras, A., Hoffmann, D. S., Eastvold, J. S., Kienzle, M. F., Gruman, L. M., Kirby, P. A., Weiss, R. M. and Davisson, R. L. (2006). Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia. Biol. Reprod. 75, 899-907. (Pubitemid 44845596)
23. Duckitt, K. and Harrington, D. (2005). Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330, 565.
24. Faas, M. M., Schuiling, G. A., Baller, J. F., Visscher, C. A. and Bakker, W. W. (1994). A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am. J. Obstet. Gynecol. 171, 158-164. (Pubitemid 24254435)
25. Falcao, S., Stoyanova, E., Cloutier, G., Maurice, R. L., Gutkowska, J. and Lavoie, J. L. (2009). Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension. Hypertension 54, 1401-1407.
26. Farina, A., Zucchini, C., De Sanctis, P., Morano, D., Sekizawa, A., Purwosunu, Y., Okai, T. and Rizzo, N. (2011). Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screening. Prenat. Diagn. 31, 181-185.
27. Figueras, F. and Gardosi, J. (2011). Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am. J. Obstet. Gynecol. 204, 288-300.
28. Fonseca, E. B., Celik, E., Parra, M., Nicolaides, K. H., Fetal Medicine Foundation Second Trimester Screening Group. (2007). Progesterone and the risk of preterm birth among women with a short cervix. N. Engl. J. Med. 357, 462-469. (Pubitemid 47204875)
29. Gadonski, G., LaMarca, B. B., Sullivan, E., Bennett, W., Chandler, D. and Granger, J. P. (2006). Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension 48, 711-716. (Pubitemid 44843876)
30. Ganaway, J. R. and Allen, A. M. (1971). Obesity predisposes to pregnancy toxemia (ketosis) of guinea pigs. Lab. Anim. Sci. 21, 40-44.
31. George, E. M., Cockrell, K., Aranay, M., Csongradi, E., Stec, D. E. and Granger, J. P. (2011). Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 57, 941-948.
32. Gille, J. H., Moore, D. G. and Sedgwick, C. J. (1977). Placental infarction: a sign of pre-eclampsia in a patas monkey (Erythrocebus patas). Lab. Anim. Sci. 27, 119-121.
33. Goetzinger, K. R., Singla, A., Gerkowicz, S., Dicke, J. M., Gray, D. L. and Odibo, A. O. (2010). Predicting the risk of pre-eclampsia between 11 and 13 weeks'gestation by combining maternal characteristics and serum analytes, PAPP-A and free beta-hCG. Prenat. Diagn. 30, 1138-1142.
34. Graham, C. H., Fitzpatrick, T. E. and McCrae, K. R. (1998). Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 91, 3300-3307. (Pubitemid 28193880)
35. Granger, J. P., LaMarca, B. B., Cockrell, K., Sedeek, M., Balzi, C., Chandler, D. and Bennett, W. (2006). Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol. Med. 122, 383-392.
36. Hennessy, A, Gillin, A. G., Painter, D. M., Kirwan, P. J., Thompson, J. F. and Horvath, J. S. (1997). Evidence for preeclampsia in a baboon pregnancy with twins. Hypertens. Pregnancy 16, 223-228. (Pubitemid 27370976)
37. Hung, T. H., Skepper, J. N. and Burton, G. J. (2001). In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am. J. Pathol. 159, 1031-1043. (Pubitemid 32847193)
38. Hunkapiller, N. M. and Fisher, S. J. (2008). Chapter 12. Placental remodeling of the uterine vasculature. Methods Enzymol. 445, 281-302.
39. Janes, S. L., Kyle, P. M., Redman, C. and Goodall, A. H. (1995). Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb. Haemost. 74, 1059-1063.
40. Johansen, M., Redman, C. W., Wilkins, T. and Sargent, I. L. (1999). Trophoblast deportation in human pregnancy - its relevance for pre-eclampsia. Placenta 20, 531-539. (Pubitemid 29391296)
41. Kanasaki, K., Palmsten, K., Sugimoto, H., Ahmad, S., Hamano, Y., Xie, L., Parry, S., Augustin, H. G., Gattone, V. H., Folkman, J. et al. (2008). Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453, 1117-1121. (Pubitemid 351871733)
42. Kaufmann, P., Black, S. and Huppertz, B. (2003). Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod. 69, 1-7.
43. Kenny, L. C., Broadhurst, D. I., Dunn, W., Brown, M., North, R. A., McCowan, L., Roberts, C., Cooper, G. J., Kell, D. B. and Baker, P. N. (2010). Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 56, 741-749.
44. Khong, T. Y., De Wolf, F., Robertson, W. B. and Brosens, I. (1986). Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br. J. Obstet. Gynaecol. 93, 1049-1059. (Pubitemid 16004866)
45. Kumasawa, K., Ikawa, M., Kidoya, H., Hasuwa, H., Saito-Fujita, T., Morioka, Y., Takakura, N., Kimura, T. and Okabe, M. (2011). Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc. Natl. Acad. Sci. USA 108, 1451-1455.
46. Kupferminc, M. J., Peaceman, A. M., Wigton, T. R., Rehnberg, K. A. and Socol, M. L. (1994). Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am. J. Obstet. Gynecol. 170, 1752-1757; discussion 1757-1759.
47. Lai, Z., Kalkunte, S. and Sharma, S. (2011). A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension 57, 505-514.
48. LaMarca, B. B., Bennett, W. A., Alexander, B. T., Cockrell, K. and Granger, J. P. (2005). Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 46, 1022-1025.
49. Leslie, K., Thilaganathan, B. and Papageorghiou, A. (2011). Early prediction and prevention of preeclampsia. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 343-354.
50. Levine, R. J., Maynard, S. E., Qian, C., Lim, K. H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H. et al. (2004). Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683.
51. Li, L., Obinata, M. and Hori, K. (2010). Role of peroxiredoxin III in the pathogenesis of pre-eclampsia as evidenced in mice. Oxid. Med. Cell. Longev. 3, 71-73.
52. Maitra, U., Davis, S., Reilly, C. M. and Li, L. (2009). Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1. J. Immunol. 182, 5763-5769.
53. Makris, A., Xu, B., Yu, B., Thornton, C. and Hennessy, A. (2006). Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 27, 445-451.
54. Makris, A., Thornton, C., Thompson, J., Thomson, S., Martin, R., Ogle, R., Waugh, R., McKenzie, P., Kirwan, P. and Hennessy, A. (2007). Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 71, 977-984. (Pubitemid 46741987)
55. Masotti, G., Galanti, G., Poggesi, L., Abbate, R. and Neri Serneri, G. G. (1979). Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 2, 1213-1217.
56. Maynard, S. E., Min, J. Y., Merchan, J., Lim, K. H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E. et al. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658.
57. McCarthy, F. P., Kingdom, J. C., Kenny, L. C. and Walsh, S. K. (2011a). Animal models of preeclampsia; uses and limitations. Placenta 32, 413-419.
58. McCarthy, F. P., Drewlo, S., Kingdom, J., Johns, E. J., Walsh, S. K. and Kenny, L. C. (2011b). Peroxisome proliferator-activated receptor-{gamma} as a potential therapeutic target in the treatment of preeclampsia. Hypertension.
59. Mess, A., Zaki, N., Kadyrov, M., Korr, H. and Kaufmann, P. (2007). Caviomorph placentation as a model for trophoblast invasion. Placenta 28, 1234-1238. (Pubitemid 47570916)
60. Orange, S., Rasko, J. E., Thompson, J. F., Vaughan, J., Olive, E., Pedler, M., Horvath, J. S. and Hennessy, A. (2005). Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine 29, 176-185. (Pubitemid 40126236)
61. Orshal, J. M. and Khalil, R. A. (2004). Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R1013-R1023. (Pubitemid 38661388)
62. Palmer, A. E., London, W. T., Sly, D. L. and Rice, J. M. (1979). Spontaneous preeclamptic toxemia of pregnancy in the patas monkey (Erythrocebus patas). Lab. Anim. Sci. 29, 102-106. (Pubitemid 9144865)
63. Redman, C. W. and Sargent, I. L. (2010). Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 63, 534-543.
64. Redman, C. W., Bonnar, J. and Beilin, L. (1978). Early platelet consumption in pre-eclampsia. Br. Med. J. 1, 467-469. (Pubitemid 8318838)
65. Reeves S. A., Gibbs, R. S., Clark, S. L. (2011). Magnesium for fetal neuroprotection. Am. J. Obstet. Gynecol. 204, 202.e1-202.e4.
66. Roberts, J. M. and Hubel, C. A. (2009). The two stage model of preeclampsia: variations on the theme. Placenta 30 Suppl. A, S32-S37.
67. Robertson, S. A., Guerin, L. R., Bromfield, J. J., Branson, K. M., Ahlstrom, A. C. and Care, A. S. (2009). Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol. Reprod. 80, 1036-1045.
68. Rogers, J. B., Klein, R. and Blumenthal, H. T. (1964). Placental permeability in a toxemia-susceptible strain of guinea pigs. Am. J. Obstet. Gynecol. 88, 495-501.
69. Rolfo, A., Many, A., Racano, A., Tal, R., Tagliaferro, A., Ietta, F., Wang, J., Post, M. and Caniggia, I. (2010). Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS ONE 5, e13288.
70. Rosario, G. X., Konno, T. and Soares, M. J. (2008). Maternal hypoxia activates endovascular trophoblast cell invasion. Dev. Biol. 314, 362-375.
71. Rossi, A. C. and Mullin, P. M. (2011). Prevention of preeclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 158, 9-16.
72. Saftlas, A. F., Olson, D. R., Franks, A. L., Atrash, H. K. and Pokras, R. (1990). Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am. J. Obstet. Gynecol. 163, 460-465. (Pubitemid 20287609)
73. Salomon, L. J., Benattar, C., Audibert, F., Fernandez, H., Duyme, M., Taieb, J. and Frydman, R. (2003). Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. Am. J. Obstet. Gynecol. 189, 1517-1522. (Pubitemid 38056417)
74. Scazzocchio, E. and Figueras, F. (2011). Contemporary prediction of preeclampsia. Curr. Opin. Obstet. Gynecol. 23, 65-71.
75. Sibai, B. M. (2004). Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet. Gynecol. 103, 981-991.
76. Sibai, B. M., Caritis, S. N., Thom, E., Klebanoff, M., McNellis, D., Rocco, L., Paul, R. H., Romero, R., Witter, F., Rosen, M. et al. (1993). Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N. Engl. J. Med. 329, 1213-1218.
77. Subtil, D., Goeusse, P., Houfflin-Debarge, V., Puech, F., Lequien, P., Breart, G., Uzan, S., Quandalle, F., Delcourt, Y. M. and Malek, Y. M. (2003). Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 2). BJOG 110, 485-491. (Pubitemid 36556131)
78. Sunderland, N. S., Thomson, S. E., Heffernan, S. J., Lim, S., Thompson, J., Ogle, R., McKenzie, P., Kirwan, P. J., Makris, A. and Hennessy, A. (2011). Tumor necrosis factor alpha induces a model of preeclampsia in pregnant baboons (Papio hamadryas). Cytokine 56, 192-199.
79. Takimoto, E., Ishida, J., Sugiyama, F., Horiguchi, H., Murakami, K. and Fukamizu, A. (1996). Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274, 995-998.
80. Takimoto-Ohnishi, E., Saito, T., Ishida, J., Ohnishi, J., Sugiyama, F., Yagami, K. and Fukamizu, A. (2005). Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy. Mol. Endocrinol. 19, 1361-1372.
81. Tal, R., Shaish, A., Barshack, I., Polak-Charcon, S., Afek, A., Volkov, A., Feldman, B., Avivi, C. and Harats, D. (2010). Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction. Am. J. Pathol. 177, 2950-2962.
82. Thorp, J. A., Walsh, S. W. and Brath, P. C. (1988). Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries. Am. J. Obstet. Gynecol. 159, 1381-1384. (Pubitemid 19021581)
83. Trogstad, L., Magnus, P. and Stoltenberg, C. (2011). Pre-eclampsia: risk factors and causal models. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 329-342.
84. Venkatesha, S., Toporsian, M., Lam, C., Hanai, J., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K. H., Yuan, H. T., Libermann, T. A. et al. (2006). Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642-649. (Pubitemid 43865232)
85. Verlohren, S., Geusens, N., Morton, J., Verhaegen, I., Hering, L., Herse, F., Dudenhausen, J. W., Muller, D. N., Luft, F. C., Cartwright, J. E. et al. (2010). Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy. Hypertension 56, 304-310.
86. Vince, G. S., Starkey, P. M., Austgulen, R., Kwiatkowski, D. and Redman, C. W. (1995). Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br. J. Obstet. Gynaecol. 102, 20-25.
87. Wagner, M. (2001). What every midwife should know about ACOG and VBAC. Critique of ACOG Practice Bulletin #5, July 1999, Vaginal birth after previous cesarean section. Midwifery Today Int. Midwife Fall, 41-43.
88. Wenzel, K., Rajakumar, A., Haase, H., Geusens, N., Hubner, N., Schulz, H., Brewer, J., Roberts, L., Hubel, C. A., Herse, F. et al. (2011). Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension 58, 77-84.
89. Wildman, D. E., Chen, C., Erez, O., Grossman, L. I., Goodman, M. and Romero, R. (2006). Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc. Natl. Acad. Sci. USA 103, 3203-3208. (Pubitemid 43346448)
90. Withington, S. L., Scott, A. N., Saunders, D. N., Lopes Floro, K., Preis, J. I., Michalicek, J., Maclean, K., Sparrow, D. B., Barbera, J. P. and Dunwoodie, S. L. (2006). Loss of Cited2 affects trophoblast formation and vascularization of the mouse placenta. Dev. Biol. 294, 67-82.
91. Woods, A. K., Hoffmann, D. S., Weydert, C. J., Butler, S. D., Zhou, Y., Sharma, R. V. and Davisson, R. L. (2010). Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice. Hypertension 57, 94-102.
92. Wu, F. T., Stefanini, M. O., Mac Gabhann, F., Kontos, C. D., Annex, B. H. and Popel, A. S. (2010). A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J. Cell. Mol. Med. 14, 528-552.
93. Zhou, C. C., Zhang, Y., Irani, R. A., Zhang, H., Mi, T., Popek, E. J., Hicks, M. J., Ramin, S. M., Kellems, R. E. and Xia, Y. (2008). Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 14, 855-862.